Ultragenyx

Price & Volume

Stats

52W Range	$18.29-$42.37
Market Cap	$2.2B
Shares Short	11M

Financials

Revenue (12 Mos)	$673M
Revenue Growth (YoY)	25.9%
Gross Profit (12 Mos)	-$186M
Diluted EPS	-$5.83

News

Yahoo Finance • 8 days ago

ULTRAGENYX URGENT DEADLINE: Bragar Eagel & Squire, P.C. Reminds Ultragenyx (NASDAQ:RARE) Investors of the April 6th Lead Plaintiff Deadline and Urges Investors to Contact the Firm

Yahoo Finance • 8 days ago

RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit with the Schall Law Firm

Yahoo Finance • 8 days ago

RARE DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ultragenyx Pharmaceutical Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - RARE

Yahoo Finance • 9 days ago

Bronstein, Gewirtz & Grossman LLC Urges Ultragenyx Pharmaceutical Inc. Investors to Act: Class Action Filed Alleging Investor Harm

About

CEO	Dr. Emil D. Kakkis M.D., Ph.D.
CFO	Mr. Howard Horn
Address	60 Leveroni Court, Novato, CA, United States, 94949
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	1,371